(Q50572139)

15 March 2018

title

Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin. (English)

1 reference

15 March 2018

1 reference

1 reference

7

K Rajender Reddy

1 reference

15 March 2018

Maria H Sjogren

1

1 reference

15 March 2018

Robert Sjogren

2

1 reference

15 March 2018

Michael F Lyons

3

1 reference

15 March 2018

Michael Ryan

4

1 reference

15 March 2018

John Santoro

5

1 reference

15 March 2018

Coleman Smith

6

1 reference

15 March 2018

Herbert Bonkovsky

8

1 reference

15 March 2018

Brooke Huntley

9

1 reference

15 March 2018

Sima Faris-Young

10

1 reference

15 March 2018

publication date

4 April 2007

1 reference

15 March 2018

Digestive Diseases and Sciences

published in

1 reference

15 March 2018

volume

52

1 reference

15 March 2018

issue

6

1 reference

15 March 2018

page(s)

1540-1547

1 reference

15 March 2018

https://scigraph.springernature.com/pub.10.1007/s10620-007-9757-9

exact match

0 references

cites work

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-9757-9

A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-9757-9

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-9757-9

The role of three domains in the biological activity of human interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-9757-9

Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C

21 January 2018

1 reference

12 December 2020

Diagnosis, management, and treatment of hepatitis C

1 reference

12 December 2020

Management of hepatitis C virus in special populations: patient and treatment considerations

1 reference

12 December 2020

The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon

1 reference

12 December 2020

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group

1 reference

12 December 2020

Consensus interferon induces peak mRNA accumulation at lower concentrations than interferon-alpha 2a

1 reference

12 December 2020

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

12 December 2020

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

12 December 2020

Screening for depression in a hepatitis C population: the reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D).

1 reference

12 December 2020

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

1 reference

12 December 2020

Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.

1 reference

12 December 2020

Side effects of therapy of hepatitis C and their management

1 reference

12 December 2020

Course and outcome of hepatitis C

1 reference

12 December 2020

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

1 reference

12 December 2020

Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C.

1 reference

12 December 2020

1 reference

12 December 2020

Predictors of response to therapy for chronic hepatitis C.

1 reference

12 December 2020

Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States

1 reference

12 December 2020

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

12 December 2020

New kinetic models for the hepatitis C virus

1 reference

12 December 2020

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

12 December 2020

10.1007/S10620-007-9757-9

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018